What is it about?

The aim of the study reported here was to assess the disease-free survival and overall survival of patients with endometrial cancer and to determine independent factors affecting the prognosis.

Featured Image

Why is it important?

FIGO stage and tumor grade were independent prognostic factors of disease-free survival and overall survival in endometrial cancer patients. Outcome was also influenced by histopathologic type, myometrial and lymphovascular space invasion, lymph-node involvement, age, and tumor remnants after surgery, although a larger study sample is probably needed to demonstrate the independent association of these variables with survival.

Perspectives

This single-center retrospective analysis confirms that FIGO stage and tumor grade are independent prognostic factors of disease-free survival and overall survival in patients diagnosed with endometrial cancer. The preoperative study is critical to define the group of patients who should undergo lymphadenectomy, depending on which is considered high or low risk. As shown, poorly differentiated tumors have a very unfavorable effect on survival and it is necessary to know this information before the patient is in the operating room. Outcome was also influenced by histopathologic tumor type, myometrial and lymphovascular space invasion, lymph-node involvement, age, and tumor remnants after surgery, although a larger study sample is probably needed to demonstrate the independent association of these variables with survival.

Professor Jesus S. Jimenez-Lopez
Hospital Universitario 12 de Octubre

Read the Original

This page is a summary of: Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients, OncoTargets and Therapy, September 2013, Taylor & Francis,
DOI: 10.2147/ott.s51532.
You can read the full text:

Read

Contributors

The following have contributed to this page